AQR Capital Management - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$808,000
+128.2%
28,738
+274.2%
0.00%
+100.0%
Q4 2021$354,000
-48.3%
7,680
-60.7%
0.00%0.0%
Q2 2021$685,000
-8.9%
19,542
-6.1%
0.00%0.0%
Q1 2021$752,000
-24.3%
20,816
-39.2%
0.00%
-50.0%
Q4 2020$994,000
-8.0%
34,240
-10.7%
0.00%0.0%
Q3 2020$1,081,000
-39.4%
38,335
-30.5%
0.00%
-33.3%
Q2 2020$1,784,000
-27.5%
55,166
-8.7%
0.00%
-25.0%
Q1 2020$2,461,000
+420.3%
60,412
+687.4%
0.00%
+300.0%
Q4 2019$473,000
+39.5%
7,672
+64.7%
0.00%
Q3 2019$339,000
-37.7%
4,658
-29.6%
0.00%
-100.0%
Q2 2019$544,000
-4.6%
6,619
-18.1%
0.00%0.0%
Q1 2019$570,000
+74.8%
8,083
+11.6%
0.00%
Q4 2018$326,000
-41.2%
7,240
-26.1%
0.00%
-100.0%
Q3 2018$554,000
+3.2%
9,792
+21.9%
0.00%0.0%
Q2 2018$537,000
-6.0%
8,035
-18.1%
0.00%0.0%
Q1 2018$571,000
+132.1%
9,808
+86.3%
0.00%
Q2 2017$246,000
-6.1%
5,264
-0.6%
0.00%
Q1 2017$262,000
+4.0%
5,296
+27.6%
0.00%
Q4 2016$252,000
-62.8%
4,152
-65.8%
0.00%
-100.0%
Q2 2016$677,000
+90.2%
12,126
+14.7%
0.00%0.0%
Q1 2016$356,000
-37.9%
10,568
-16.7%
0.00%0.0%
Q4 2015$573,000
-26.8%
12,688
-36.0%
0.00%
-50.0%
Q3 2015$783,000
-65.0%
19,829
-45.0%
0.00%
-50.0%
Q2 2015$2,236,000
-16.5%
36,024
-15.8%
0.00%
-33.3%
Q1 2015$2,678,000
-55.6%
42,805
-60.0%
0.01%
-53.8%
Q4 2014$6,029,000
+125.8%
106,905
+13.2%
0.01%
+85.7%
Q3 2014$2,670,00094,4000.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders